Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Covalon Technologies Ltd

COV.V ✓ COMPLIANT ☆ Track — members

TSX · Healthcare · Medical Equipment, Supplies & Distribution ·

Canada Micro Cap Analyst: BUY

Last Close

$2.38

▲ +0.00%

Market Cap $65.90M · Vol 12.03K

Key Metrics

P/E Ratio

20.90

FWD: 16.73

Market Cap

$65.90M

Micro Cap

Div Yield

N/A

Dividend with no set frequency

EPS Growth

+141.37%

YoY

RSI (14)

82.05

Momentum

Beta

0.24

vs Market

52W High

$2.59

8.52% below

52W Low

$1.12

108.01% above

Volume

12.03K

Avg 22.49K

P/B

1.75

Price-to-book

ROE

7.07%

Return on equity

Free Float

52.84%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Covalon Technologies Ltd (COV.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does COV.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+8.20%

+41.03%

+54.21%

+83.33%

YTD

+89.66%

+59.27%

+116.22%

+26.28%

Financials & Valuation

TTM · Annual

Total Revenue	$23.57M
Net Income	$1.48M
Revenue Growth (YoY)	+19.93%
Gross Margin	53.24%
Operating Margin	5.37%
Net Profit Margin	6.27%
ROE	7.07%
ROA · ROIC	6.06% · N/A

P/E Ratio	20.90
Forward P/E (FY1)	16.73
PEG Ratio	-0.86
P/S	1.67
P/B	1.75
P/FCF	37.92
EPS Growth	+141.37%
Outstanding Shares	27.62M

Technical Indicators

50-Day SMA	$1.74
200-Day SMA	$1.45
RSI (14)	82.05
Beta	0.24
52-Week High	$2.59
52-Week Low	$1.12

Volume Today	12.03K
Avg Daily Volume (30D)	22.49K
Relative Volume	0.54x
Volatility (10D)	58.09
Volatility (30D)	78.64
Free Float	52.84%

Analyst Consensus

BUY

Current Price $2.38

Mean Target $2.11

52W Low$1.12 52W High$2.59

Current

Target

$1.12 $2.59

Current Analyst target

-11.34% downside risk · 1 analysts

Identifiers

ExchangeTSX

FIGIBBG001SHNX10

ISINCA22282D3022

CountryCanada

Sub-IndustryMedical Supplies

Earnings DateDec 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

COLO B.CO Coloplast A/S -3.86% 603301.SS Zhende Medical Co Ltd -3.46% 300888.SZ Winner Medical Co Ltd -2.86% 300529.SZ Jafron Biomedical Co Ltd -1.64% 1066.HK Shandong Weigao Group Medical Polymer Co Ltd -1.75%

Company Profile

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon's name, and by developing and commercializing medical products for other medical companies under development and license contracts. The Company has three proprietary platform technologies that have the potential to be developed into a number of medical devices and products: Collagen matrix, Antimicrobial silicone adhesive and Medical coatings. Its product type includes advanced wound care, antimicrobial dressings, collagen dressings, IV dressings, and perioperative dressings. Its brands include ColActive PLUS, CovaClear, CovaView, CovaWound, IV Clear, SurgiClear, and VALGuard.